Free Trial

Ventyx Biosciences (VTYX) Competitors

Ventyx Biosciences logo
$2.37 +0.12 (+5.33%)
(As of 12/17/2024 ET)

VTYX vs. CRGX, EXAI, ORIC, TERN, VECT, TRML, PHAT, PROK, DNA, and ANNX

Should you be buying Ventyx Biosciences stock or one of its competitors? The main competitors of Ventyx Biosciences include CARGO Therapeutics (CRGX), Exscientia (EXAI), ORIC Pharmaceuticals (ORIC), Terns Pharmaceuticals (TERN), VectivBio (VECT), Tourmaline Bio (TRML), Phathom Pharmaceuticals (PHAT), ProKidney (PROK), Ginkgo Bioworks (DNA), and Annexon (ANNX). These companies are all part of the "pharmaceutical products" industry.

Ventyx Biosciences vs.

Ventyx Biosciences (NASDAQ:VTYX) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings, risk and community ranking.

Ventyx Biosciences currently has a consensus price target of $10.00, indicating a potential upside of 321.94%. CARGO Therapeutics has a consensus price target of $31.80, indicating a potential upside of 115.45%. Given Ventyx Biosciences' higher possible upside, analysts clearly believe Ventyx Biosciences is more favorable than CARGO Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ventyx Biosciences
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
CARGO Therapeutics
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

97.9% of Ventyx Biosciences shares are held by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are held by institutional investors. 18.2% of Ventyx Biosciences shares are held by insiders. Comparatively, 1.4% of CARGO Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Ventyx Biosciences received 17 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. However, 100.00% of users gave CARGO Therapeutics an outperform vote while only 47.69% of users gave Ventyx Biosciences an outperform vote.

CompanyUnderperformOutperform
Ventyx BiosciencesOutperform Votes
31
47.69%
Underperform Votes
34
52.31%
CARGO TherapeuticsOutperform Votes
14
100.00%
Underperform Votes
No Votes

CARGO Therapeutics' return on equity of -38.16% beat Ventyx Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Ventyx BiosciencesN/A -54.94% -50.01%
CARGO Therapeutics N/A -38.16%-33.94%

In the previous week, CARGO Therapeutics had 1 more articles in the media than Ventyx Biosciences. MarketBeat recorded 4 mentions for CARGO Therapeutics and 3 mentions for Ventyx Biosciences. Ventyx Biosciences' average media sentiment score of 0.78 beat CARGO Therapeutics' score of 0.52 indicating that Ventyx Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Ventyx Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
CARGO Therapeutics
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

CARGO Therapeutics is trading at a lower price-to-earnings ratio than Ventyx Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ventyx BiosciencesN/AN/A-$192.96M-$2.36-1.00
CARGO TherapeuticsN/AN/A-$98.15M-$4.26-3.46

Summary

Ventyx Biosciences and CARGO Therapeutics tied by winning 7 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VTYX vs. The Competition

MetricVentyx BiosciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$167.58M$6.86B$5.17B$9.32B
Dividend YieldN/A3.06%4.78%4.06%
P/E Ratio-1.0010.75127.7717.55
Price / SalesN/A285.811,261.39139.05
Price / CashN/A56.6541.0437.95
Price / Book0.575.394.894.92
Net Income-$192.96M$151.81M$119.40M$225.78M
7 Day Performance-14.75%-5.54%14.54%-1.47%
1 Month Performance26.74%0.33%17.43%5.36%
1 Year Performance5.33%16.04%35.31%22.71%

Ventyx Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VTYX
Ventyx Biosciences
3.229 of 5 stars
$2.37
+5.3%
$10.00
+321.9%
+5.3%$167.58MN/A-1.0073News Coverage
CRGX
CARGO Therapeutics
1.8446 of 5 stars
$13.98
+1.7%
$31.80
+127.5%
-18.7%$643.47MN/A-3.23116
EXAI
Exscientia
1.2867 of 5 stars
$4.84
+3.2%
$7.00
+44.6%
-17.5%$632.93M$25.60M-3.21280High Trading Volume
ORIC
ORIC Pharmaceuticals
3.775 of 5 stars
$8.45
-0.8%
$18.29
+116.4%
-11.4%$596.32MN/A-4.6880Insider Trade
News Coverage
Positive News
Gap Down
TERN
Terns Pharmaceuticals
4.2241 of 5 stars
$6.97
+3.6%
$18.30
+162.6%
+7.1%$592.03M$1M-5.7040
VECT
VectivBio
N/A$16.85
flat
N/AN/A$573.24M$27.34M0.0030
TRML
Tourmaline Bio
2.1359 of 5 stars
$22.34
+2.4%
$54.00
+141.7%
+9.3%$572.87MN/A-7.7344
PHAT
Phathom Pharmaceuticals
2.9256 of 5 stars
$8.34
+5.7%
$23.00
+175.8%
-4.0%$570.29M$680,000.00-1.48110Gap Up
PROK
ProKidney
2.3102 of 5 stars
$1.92
+6.7%
$4.50
+135.0%
+3.9%$558.53MN/A-3.553Positive News
DNA
Ginkgo Bioworks
0.7441 of 5 stars
$9.65
+2.2%
$4.58
-52.6%
N/A$554.68M$251.46M-0.721,218News Coverage
Positive News
ANNX
Annexon
2.4011 of 5 stars
$5.18
+16.7%
$15.80
+205.0%
+74.9%$552.16MN/A-4.9060Analyst Forecast
News Coverage

Related Companies and Tools


This page (NASDAQ:VTYX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners